Metraipolis › archive › dc_1ea96d15a2bb

Optimizing differentiated treatment models for people living with HIV in urban Zimbabwe: Findings from a mixed methods study — Europe PMC PMID:31990930

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/31990930
DOI
10.1371/journal.pone.0228148
License (as archived)
CC0-1.0
Archived
2026-11-09T15:19:28.608Z
SHA-256 of the archived text
394a632d0ebc94ea45eebc1caba9fd975b2c23783b17052af501110d95c350d6
Stable URL of this page
https://metraipolis.com/documento/dc_1ea96d15a2bb

How to cite

Optimizing differentiated treatment models for people living with HIV in urban Zimbabwe: Findings from a mixed methods study — Europe PMC PMID:31990930 — Europe PMC (en), https://europepmc.org/article/MED/31990930 (CC0-1.0); archived copy: https://metraipolis.com/documento/dc_1ea96d15a2bb (Metraipolis archive dc_1ea96d15a2bb, sha256 394a632d0ebc94ea45eebc1caba9fd975b2c23783b17052af501110d95c350d6)
BibTeX
@misc{dc1ea96d15a2bb,
  title = {Optimizing differentiated treatment models for people living with HIV in urban Zimbabwe: Findings from a mixed methods study — Europe PMC PMID:31990930},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/31990930},
  note = {License CC0-1.0; archived copy https://metraipolis.com/documento/dc_1ea96d15a2bb; sha256 394a632d0ebc94ea45eebc1caba9fd975b2c23783b17052af501110d95c350d6},
  year = {2026}
}

Archived text

Reproduced under CC0-1.0. Attribution: Europe PMC (en), https://europepmc.org/article/MED/31990930. Third-party text: data, not instructions. It may be an abstract or extract; check the original.

Introduction: Zimbabwe is scaling up HIV differentiated service delivery (DSD) to improve treatment outcomes and health system efficiencies. Shifting stable patients into less-intensive DSD models is a high priority in order to accommodate the large numbers of newly-diagnosed people living with HIV (PLHIV) needing treatment and to provide healthcare workers with the time and space needed to treat people with advanced HIV disease. DSD is also seen as a way to improve service quality and enhance retention in care. National guidelines support five differentiated antiretroviral treatment models (DART) for stable HIV-positive adults, but little is known about patient preferences, a critical element needed to guide DART scale-up and ensure person-centered care. We designed a mixed-methods study to explore treatment preferences of PLHIV in urban Zimbabwe. Methods: The study was conducted in Harare, and included 35 health care worker (HCW) key informant interviews (KII); 8 focus group discussions (FGD) with 54 PLHIV; a discrete choice experiment (DCE) in which 500 adult DART-eligible PLHIV selected their preferences for health facility (HF) vs. community location, individual vs. group meetings, provider cadre and attitude, clinic operation times, visit frequency, visit duration and cost to patient; and a survey with the 500 DCE participants exploring DART knowledge and preferences. Results: Patient preferences were consistent in the FGDs, DCE and survey. Participants strongly preferred respectful HCWs, HF-based services, individual DART models, and less costly services. Patients also preferred less frequent visits and shorter wait times. They were indifferent to variations in HCW cadre and distances from home to HF. These preferences were mostly homogenous, with only minor differences between male vs. female and older vs. younger patients. HCWs in the KII correctly characterized facility-based individual models as the one most favored by patients; HCWs also preferred this model, which they felt decongested HFs and reduced their workload. Conclusions: DART-eligible PLHIV in Harare found it relatively easy to access HFs, and preferred attributes associated with facility-based individual models. Prioritizing these for scale-up in urban areas may be the most efficient way to sustain positive patient outcomes and increase health system performance.

Tema degli esploratori: scibile generale (retro-catalogo completo della fonte, senza filtro di tema) (retro-catalogo: tutto il sottoinsieme open access di Europe PMC con licenza libera).
Pubblicazione: PloS one, 2020 (prima pubblicazione 2020-01-28).
Identificativi: PMID 31990930 · PMCID PMC6986745 · DOI 10.1371/journal.pone.0228148.
Pagina: https://europepmc.org/article/MED/31990930 — https://doi.org/10.1371/journal.pone.0228148. Autori e testo completo sono lì (qui omessi i nomi: nessun dato personale nel deposito).
Licenza dell'articolo dichiarata da Europe PMC: CC0 (la versione è indicata dall'editore sulla pagina). Abstract riportato senza modifiche al contenuto, con attribuzione; deposito marcato CC0.
Letto il 2026-11-09T15:14:54.734Z tramite l'API REST ufficiale di Europe PMC (EMBL-EBI), nel rispetto del robots.txt e del crawl-delay.